Source:http://linkedlifedata.com/resource/pubmed/id/21268543
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-1-27
|
pubmed:abstractText |
Hepatitis C virus (HCV) is a major public health problem worldwide, which causes high rate of chronic liver disease such as liver cirrhosis and hepatocellular carcinoma. Plasma transforming growth factor Beta-1 (TGFB-1) is a member of large family of peptides, which has a major regulatory role in hepatic fibrosis and cirrhosis. The study evaluated the role of transforming growth factor Beta-1 (TGFB-1) in induction of fibrosis in liver parasites-free HCV patients with related steatohepatitis. Thirty HCV patients who were clinically and serologically positive were selected. They were diagnosed as fatty liver by abdominal ultrasonography; steatohepatitis and confirmed by histopathological biopsies examination. ELISA evaluated plasma transforming growth factor Beta-1 (TGFB-1) level. Also, 12 cross-matched subjects clinically, parasitologically and serologically free were used as a controls. The level of plasma transforming growth factor Beta-1 (TGFB-1) was highly elevated in the patients versus controls with mean +/- SD 18739.86 +/- 18539.46 and 6465 +/- 1142 respectively (P < 0.001). The TGFB-1 level in HCV related steato-hepatitis was elevated in all grades in contrast to controls (P < 0.05), without relation between the TGFB-1 levels and steatohepatitis severity. The TGFB-1 level showed high significant difference in all stages of fibrosis in patients in contrast to controls and the TGFB-1 level was very high when fibrosis started in stage I (P < 0.01) and tended to decrease in fibrosis of stage 2 & 3 (P < 0.05). There was highly significant positive correlation between TGFB-1 and body mass index (BMI) r = 0.774.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0253-5890
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
759-72
|
pubmed:meshHeading |
pubmed-meshheading:21268543-Adult,
pubmed-meshheading:21268543-Fatty Liver,
pubmed-meshheading:21268543-Female,
pubmed-meshheading:21268543-Hepacivirus,
pubmed-meshheading:21268543-Hepatitis C,
pubmed-meshheading:21268543-Humans,
pubmed-meshheading:21268543-Liver Cirrhosis,
pubmed-meshheading:21268543-Male,
pubmed-meshheading:21268543-Middle Aged,
pubmed-meshheading:21268543-Transforming Growth Factor beta1,
pubmed-meshheading:21268543-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
The role of plasma transforming growth factor beta-1 in the development of fibrosis in patient with HCV related steatohepatitis.
|
pubmed:affiliation |
Department of Tropical Medicine, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt.
|
pubmed:publicationType |
Journal Article
|